R&D/ Views & Analysis/ Views and analysis Ardelyx’s ambition to revolutionise kidney treatment Catherine Longworth Ardelyx, COVID-19, hyperphosphatemia, kidney disease, kidneys, Tempanor 0 Comment A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company Share X Ardelyx’s ambition to revolutionise kidney treatment https://pharmaphorum.com/r-d/views-analysis-r-d/ardelyxs-ambition-to-revolutionise-kidney-treatment/
Ardelyx, COVID-19, hyperphosphatemia, kidney disease, kidneys, Tempanor
0 Comment
